Jake Galson in

Jake Galson

Login to view DISC.
Vice President of Technology at Alchemab Therapeutics Ltd
📍 Greater Cambridge Area, United Kingdom

Jake is the Vice President of Technology at Alchemab Therapeutics, where he leads the development of a pioneering discovery platform using AI to identify novel therapeutics. A University of Oxford PhD graduate, he previously led bioinformatics at Kymab Ltd, developing the IntelliSelect® antibody discovery platform, and is recognized as a pioneer in immune receptor repertoire sequencing.

Driven by personal experience, Jake co-founded Phylax Technologies with his brother to develop tools that support people with neurodegenerative diseases like Alzheimers. This venture aims to help prevent accidental online purchases, addressing a common challenge for those with cognitive decline and their families.

He was inspired to start Phylax after a person he knew with young-onset Alzheimers experienced difficulties with accidental online shopping.

Read the full overview →
Experience
12 Years
Current Role
Vice President of Technology
Job Level
Senior
Location
Greater Cambridge Area, United Kingdom
Personality Overview

How Jake shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Jake cares about

AI in Drug Discovery
Leads Alchemab's technology platform integrating AI and immune system analysis to find new antibody therapeutics and targets, a central theme of his career and public commentary.
Antibody Therapeutics
His work at Alchemab and Kymab focuses on discovering novel antibodies. He follows industry developments like open-source antibody-antigen prediction models and de novo antibody design.
+5 more topics Login to view topics
Career

Work history

7-2023
Vice President of Technology
Alchemab Therapeutics Ltd
2-2023
Co-Founder
Phylax Technologies Ltd
1-2021 - 7-2023
Head Of Technology
Alchemab Therapeutics Ltd
3-2020 - 1-2021
Director Of Technology
Alchemab Therapeutics Ltd
5-2019 - 3-2020
Group Leader, Bioinformatics
Kymab Ltd
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2012 - 2016
Doctor of Philosophy - PhD
University of Oxford
2008 - 2011
BA
University of Oxford
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Jake. Free, 10 seconds.